Based on the upregulation of IL-6 and JNK signaling identified in KD-induced MASH, we investigated whether inhibiting IL-6-gp130 signaling in the liver could rescue mice from KD-induced MASLD. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.